Your Mounjaro price guide · October 2026
Weight Loss and Appetite Suppressant Pills: What Works in the UK (October 2026)
Yes, two licensed GLP-1 weight-loss tablets now exist in the UK: Wegovy tablets and Foundayo. Both are prescription-only and reduce appetite through the GLP-1 pathway. Over-the-counter "appetite suppressant" pills and supplements have far weaker evidence and are not licensed for this use. Orlistat is licensed but blocks some fat absorption rather than suppressing appetite. This is the position as of October 2026.2021
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Prescription GLP-1 tablets (Wegovy tablets, Foundayo) are the only licensed pills that act on appetite for weight loss in the UK.
-
Orlistat is a licensed tablet, but it works on fat absorption and gives smaller average losses.
-
Supplements sold as "natural Ozempic" are not medicines and have no comparable trial evidence.
-
There is no tablet form of Mounjaro; tirzepatide is an injection only.
-
A GPhC-registered prescriber decides which option suits your health, medicines and routine.
In this guide
01 · The core answer
Do appetite suppressant pills work for weight loss?
It depends entirely on which pill. Licensed prescription tablets produce meaningful average weight loss in trials, while shop-bought appetite suppressants have no comparable evidence and no clinical oversight.
The two prescription tablets work by acting on the GLP-1 receptor, the same hormone pathway used by weight-loss injections. They are used alongside a reduced-calorie diet and more physical activity. Individual results vary.2021
| Option | Type | How it works | Evidence level |
|---|---|---|---|
| Wegovy tablets (oral semaglutide) | Prescription tablet, once daily | GLP-1 medicine | Licensed, OASIS 4 trial |
| Foundayo (orforglipron) | Prescription tablet, once daily | GLP-1 medicine | Licensed, ATTAIN-1 trial |
| Orlistat | Licensed tablet | Blocks some dietary fat absorption | Smaller average losses |
| Berberine and similar supplements | Not a medicine | Not regulated for this use | No comparable trial evidence; low-cost supplement, no clinical oversight |
| Mounjaro (tirzepatide) | Weekly injection, not a pill | Activates GIP and GLP-1 receptors | Licensed, SURMOUNT trials |
No trial has compared Mounjaro directly with either tablet, so do not set their headline results side by side.15
02 · Your decision
What should you do next?
If you have a BMI of 30 or above, or 27 or above with a weight-related condition, you may be eligible for a licensed treatment. Start with a free consultation, reviewed by a GPhC-registered prescriber, who can discuss tablets and injections with you. Our weight loss clinic explains how this works.
If you prefer a once-weekly routine, the Mounjaro pen is the injectable option: your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). For tablets, see the Wegovy pill and Foundayo pages for current prices.
03 · Wegovy tablets
Wegovy tablets: the appetite-reducing pill with a strict routine
Wegovy tablets contain semaglutide, the same active ingredient as the Wegovy injection, taken as one tablet once a day. They are licensed for weight management in adults with a BMI of 30 or above, or 27 to under 30 with at least one weight-related condition.20
The routine is demanding. The tablet must be taken on an empty stomach after fasting for at least 8 hours, swallowed whole with a sip of water (up to half a glass, about 120ml), and you then wait at least 30 minutes before eating, drinking or taking other tablets. Treatment starts at a low dose and steps up gradually, with at least one month at each dose.20
In the OASIS 4 trial, adults taking semaglutide 25mg tablets for 64 weeks lost on average 13.6% of their body weight, compared with 2.2% on placebo.22 Individual results vary. The most common side effects are digestive: nausea, vomiting, diarrhoea, constipation, indigestion and stomach pain, along with headache and tiredness.22
04 · Foundayo
Foundayo: a GLP-1 tablet without food or water rules
Foundayo contains orforglipron, a once-daily GLP-1 tablet made by Eli Lilly, the maker of Mounjaro. Unlike Wegovy tablets it can be taken at any time of day, with or without food and without water restrictions. It has the same licensed BMI criteria as Wegovy tablets.21
In the ATTAIN-1 trial of 3,127 adults without type 2 diabetes, people taking the highest dose of orforglipron for 72 weeks lost on average 12.4% of their body weight, compared with 0.9% on placebo; the two lower doses gave 7.8% and 9.3%.23 The trial used capsules, so tablet and capsule doses are not comparable milligram for milligram.
The most common side effects are digestive. Foundayo may make oral contraceptive pills less effective: switch to a non-oral method or add a barrier method for 30 days after starting and for 30 days after each dose increase.21
05 · Orlistat and supplements
Orlistat, supplements and "natural" suppressants
Orlistat is a licensed tablet, but it is not an appetite suppressant. It blocks some dietary fat absorption and produces smaller average losses than the GLP-1 medicines.
"Natural GLP-1" supplements, such as berberine, are not medicines. They are not regulated for this use and have no comparable trial evidence. They are available cheaply without assessment, and dosing is not standardised. That low barrier is a safety concern, not a benefit: nobody checks whether the product suits your health or other medicines.
This is also the honest answer to "how can I mimic Ozempic naturally?". No supplement reproduces a GLP-1 medicine. Our guides on natural appetite suppressant pills and whether weight loss pills work go into more detail.
06 · Tablet versus injection
Is there a tablet equivalent to Mounjaro?
No. There is no tablet form of Mounjaro, because tirzepatide is injection-only in the UK. Wegovy tablets and Foundayo are different medicines with their own dosing, eligibility checks and trial results.1
Mounjaro is a once-weekly injection, while the tablets are taken daily. The practical differences matter as much as the averages: Wegovy tablets need a strict empty-stomach routine every morning, Foundayo has no food or water rules, and Mounjaro needs one injection a week. A prescriber will check which option is suitable for your health, your other medicines and your routine.2021
SURMOUNT-5 is the trial that compared tirzepatide directly with injected semaglutide.15 If you want to understand the injectable route, read about a weight loss appetite suppressant injection or our prescription appetite suppressant shot guide.
07 · Safety and red flags
Safety: what to avoid when buying diet pills online
Be cautious of any seller offering to supply without a consultation or prescription, or promising specific results. Dramatic weight-loss claims are a warning sign, not a selling point.
Never combine prescription GLP-1 medicines with each other. Mounjaro must not be combined with other GLP-1 medicines, unlicensed "research" peptides, or compounded copies, because these combinations have no safety data and no regulated supply chain. If something promises faster results outside a licensed pathway, that is the warning sign.
Report suspected side effects or counterfeit medicines through the Yellow Card scheme.7 We are a GPhC-registered pharmacy (9012878), and every prescription order is reviewed by a GPhC-registered prescriber. Unsuitable orders are refunded automatically.
For wider comparisons, see our guides to appetite suppressant medication and how diet pills work.
08 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
09 · NHS access
What about the NHS?
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46
Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. Ask your GP what is available locally.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhich weight loss pills suppress appetite?
Do appetite suppressant pills work for weight loss?
Is there a pill that makes you lose your appetite?
Is there a tablet equivalent to Mounjaro?
Is there an effective over-the-counter weight loss pill?
How can I mimic Ozempic naturally?
What did Kelly Clarkson take to lose weight?
Can I take appetite suppressant pills with Mounjaro?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 10 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- MHRA — guidance on contraception with GLP-1/GIP medicines; counterfeit medicine alerts and Yellow Card scheme
- GPhC — public register of pharmacies and pharmacy professionals
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med 2025
- Wegovy tablets (oral semaglutide) — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Foundayo (orforglipron) film-coated tablets — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity (OASIS 4). N Engl J Med 2025
- Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, for Obesity Treatment (ATTAIN-1). N Engl J Med 2025
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


